<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>POTASSIUM CHLORIDE - potassium chloride injection, solution, concentrate </strong><br>Physicians Total Care, Inc.<br></p></div>
<h1></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Warning">
<a name="section-1"></a><p></p>
<p class="First">R<span class="Sub">x</span> only</p>
<a href="http://"></a><a href="http://"></a><p><span class="Bold">CONCENTRATE</span></p>
<p><span class="Italics">MUST BE DILUTED BEFORE USE.</span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<p class="First"><span>FOR INTRAVENOUS INFUSION ONLY;</span></p>
<p><span>MUST BE DILUTED PRIOR TO INJECTION</span><span class="Bold">.</span></p>
<p><span class="Bold">Ampuls</span></p>
<p><span class="Bold">Fliptop Vials</span></p>
<p><span class="Bold">Pintop Vials</span></p>
<p><span class="Bold">Pressurized Pintop Vials</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>Potassium Chloride for Injection Concentrate, USP, is a sterile, nonpyrogenic, 
concentrated solution of potassium chloride, USP in water for injection 
administered by intravenous infusion only after dilution in a larger volume of 
fluid. They are provided in the following variety of concentrations and sizes 
comprising a choice of single-dose containers, all designed to provide the 
commonly prescribed amounts of potassium chloride for single-dose infusion after 
dilution in suitable large volume parenterals.<a name="i7eb976ba-73af-444f-8adb-3ff0c19910ad"></a><table width="40%"><tbody class="Headless">
<tr class="First">
<td><span class="Bold">Additive Solution*<br>(conc. &amp; size)<br></span></td>
<td>K<span class="Sup">+</span><br>mEq/mL<br>
</td>
<td>KCl<br>mg/mL<br>
</td>
<td>mOsmol/mL<br>(calc.)<br>
</td>
</tr>
<tr>
<td>30 mEq/20 mL<br>
</td>
<td>1.5<br>
</td>
<td>112<br>
</td>
<td>3<br>
</td>
</tr>
<tr>
<td>10 mEq/5 mL<br>
</td>
<td>2<br>
</td>
<td>149<br>
</td>
<td>4<br>
</td>
</tr>
<tr>
<td>20 mEq/10 mL<br>
</td>
<td>2<br>
</td>
<td>149<br>
</td>
<td>4<br>
</td>
</tr>
<tr>
<td>30 mEq/15 mL<br>
</td>
<td>2<br>
</td>
<td>149<br>
</td>
<td>4<br>
</td>
</tr>
<tr class="Last">
<td>40 mEq/20 mL<br>
</td>
<td>2<br>
</td>
<td>149<br>
</td>
<td>4<br>
</td>
</tr>
</tbody></table>*  May contain hydrochloric acid for pH adjustment.<br><br><p class="First">The solutions contain no bacteriostat, antimicrobial agent or added buffer 
(except for pH adjustment) and each is intended only for single-dose injection 
(after dilution). When smaller doses are required, discard the unused portion. 
The pH is 4.6 (4.0 to 8.0).</p>
<p>Potassium Chloride for Injection Concentrate, USP (appropriately diluted) is 
a parenteral fluid and electrolyte replenisher.</p>
<p>Potassium Chloride, USP is chemically designated KCl, a white granular powder 
freely soluble in water.</p>
<p>The semi-rigid material used for the plastic vials is fabricated from a 
specially formulated polyolefin. It is a copolymer of ethylene and propylene. 
The safety of the plastic has been confirmed by tests in animals according to 
USP biological standards for plastic containers. The container requires no vapor 
barrier to maintain the proper drug concentration.</p>
<br>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Potassium is the chief cation of body cells (160 mEq/liter of 
intracellular water) and is concerned with the maintenance of body fluid 
composition and electrolyte balance. Potassium participates in carbohydrate 
utilization and protein synthesis, and is critical in the regulation of nerve 
conduction and muscle contraction, particularly in the heart. Chloride, the 
major extracellular anion, closely follows the metabolism of sodium, and changes 
in the acid-base balance of the body are reflected by changes in the chloride 
concentration.</p>
<p>Normally about 80 to 90% of the potassium intake is excreted in the urine, 
the remainder in the stools and, to a small extent, in perspiration. The kidney 
does not conserve potassium well so that during fasting, or in patients on a 
potassium-free diet, potassium loss from the body continues, resulting in 
potassium depletion. A deficiency of either potassium or chloride will lead to a 
deficit of the other.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Potassium Chloride for Injection Concentrate, USP is indicated in the treatment 
of <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">potassium deficiency</span> states when oral replacement is not feasible. </p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Potassium Chloride for Injection Concentrate, USP is contraindicated in diseases 
where high potassium levels may be encountered, and in patients with 
<span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>, <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal failure</span> and in conditions in which potassium retention is 
present.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">To avoid potassium <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span>, do not infuse solutions rapidly. 
In patients with severe <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span>, administration of potassium 
chloride may cause potassium <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> and life threatening <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>.</p>
<p>The administration of intravenous solutions can cause fluid and/or solute 
overload resulting in dilution of serum electrolyte concentrations, 
<span class="product-label-link" type="condition" conceptid="4266976" conceptname="Overhydration">overhydration</span>, congested states or <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span>.</p>
<p>The risk of dilutional states is inversely proportional to the electrolyte 
concentration. The risk of solute overload causing congested states with 
peripheral and <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span> is directly proportional to the electrolyte 
concentration.</p>
<p>WARNING: This product contains aluminum that may be toxic. Aluminum may reach 
toxic levels with prolonged parenteral administration if kidney function is 
impaired. Premature neonates are particularly at risk because their kidneys are 
immature,and they require large amounts of calcium and phosphate solutions, 
which contain aluminum.</p>
<p>Research indicates that patients with impaired kidney function, including 
premature neonates, who receive parenteral levels of aluminum at greater than 4 
to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous 
system and bone toxicity. Tissue loading may occur at even lower rates of 
administration.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<a href="http://"></a>General<p class="First">Clinical evaluation and periodic laboratory determinations are 
necessary to monitor changes in fluid balance, electrolyte concentrations, and 
acid-base balance during prolonged parenteral therapy or whenever the condition 
of the patient warrants such evaluation. Significant deviations from normal 
concentrations may require the use of additional electrolyte supplements, or the 
use of electrolyte-free dextrose solutions to which individualized electrolyte 
supplements may be added.</p>
<p>Potassium therapy should be guided primarily by serial electrocardiograms, 
especially in patients receiving digitalis. Serum potassium levels are not 
necessarily indicative of tissue potassium levels. Solutions containing 
potassium should be used with caution in the presence of cardiac disease, 
particularly in the presence of <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>, and in such instances, cardiac 
monitoring is recommended.</p>
<p>Solutions containing dextrose should be used with caution in patients with 
overt or known <span class="product-label-link" type="condition" conceptid="44808385" conceptname="Pre-diabetes">subclinical diabetes</span> mellitus, or carbohydrate intolerance for 
any reason.</p>
<p>If the administration is controlled by a pumping device, care must be taken 
to discontinue pumping action before the container runs dry or <span class="product-label-link" type="condition" conceptid="4156949" conceptname="Air embolism">air embolism</span> may 
result.</p>
<a href="http://"></a><a href="http://"></a>Pregnancy<p><span class="Italics">Teratogenic Effects</span>: Pregnancy 
category C. Animal reproduction studies have not been conducted with potassium 
chloride. It is also not known whether potassium chloride can cause fetal harm 
when administered to a pregnant woman or can affect reproduction capacity. 
Potassium chloride should be given to a pregnant woman only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Reactions which may occur because of the solution or the 
technique of administration include febrile response, <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> at the site of 
injection, <span class="product-label-link" type="condition" conceptid="444247" conceptname="Venous thrombosis">venous thrombosis</span> or <span class="product-label-link" type="condition" conceptid="318174" conceptname="Phlebitis">phlebitis</span> extending from the site of injection, 
<span class="product-label-link" type="condition" conceptid="4295895" conceptname="Extravasation">extravasation</span>, <span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">hypervolemia</span>, and <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>.</p>
<p>Too rapid infusion of hypertonic solutions may cause local <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> and, rarely, 
vein irritation. Rate of administration should be adjusted according to 
tolerance. </p>
<p>Reactions reported with the use of potassium-containing solutions include 
<span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span> and <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>. The signs and symptoms of 
potassium <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> include <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesias</span> of the extremities, <span class="product-label-link" type="condition" conceptid="4290597" conceptname="Absent reflex">areflexia</span>, 
muscular or <span class="product-label-link" type="condition" conceptid="4275136" conceptname="Paralysis of diaphragm">respiratory paralysis</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">mental confusion</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, 
<span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>, <span class="product-label-link" type="condition" conceptid="316135" conceptname="Atrioventricular block">heart block</span>, electrocardiographic abnormalities and cardiac 
arrest. Potassium deficits result in disruption of neuromuscular function, and 
intestinal <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">ileus</span> and dilatation.</p>
<p>If an adverse reaction does occur, discontinue the infusion, evaluate the 
patient, institute appropriate therapeutic countermeasures and save the 
remainder of the fluid for examination if deemed necessary.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-9"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">In the event of <span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">fluid overload</span> during parenteral therapy, 
re-evaluate the patient’s condition, and institute appropriate corrective 
treatment.</p>
<p>In the event of overdosage with potassium-containing solutions, discontinue 
the infusion immediately, and institute corrective therapy to reduce serum 
potassium levels.</p>
<p>Treatment of <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> includes the following:</p>
<ol>
<li><p class="First">Dextrose Injection USP, 10% or 25%, containing 10 units of 
crystalline insulin per 20 grams of dextrose administered intravenously, at a 
rate of 300 to 500 mL per hour.</p></li>
<li><p class="First">Absorption and exchange of potassium using sodium or ammonium 
cycle cation exchange resin, orally and as retention enema.</p></li>
<li><p class="First">Hemodialysis and peritoneal dialysis. The use of 
potassium-containing foods or medications must be eliminated. However, in cases 
of digitalization, too rapid a lowering of plasma potassium concentration can 
cause <span class="product-label-link" type="condition" conceptid="433667" conceptname="Poisoning by tetanus vaccine">digitalis toxicity</span>.</p></li>
</ol>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-10"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Potassium Chloride for Injection Concentrate, USP must be diluted 
before administration. Care must be taken to ensure there is complete mixing of 
the potassium chloride with the large volume fluid, particularly if soft or bag 
type containers are used.</p>
<p>The dose and rate of administration are dependent upon the specific condition 
of each patient.</p>
<p>If the serum potassium level is greater than 2.5 mEq/liter, potassium can be 
given at a rate not to exceed 10 mEq/hour in a concentration of up to 40 
mEq/liter. The 24-hour total dose should not exceed 200 mEq.</p>
<p>If urgent treatment is indicated (serum potassium level less than 2.0 
mEq/liter with electrocardiographic changes and/or muscle <span class="product-label-link" type="condition" conceptid="440377" conceptname="Paralysis">paralysis</span>) potassium 
chloride may be infused very cautiously at a rate of up to 40 mEq/hour. In such 
cases, continuous cardiac monitoring is essential. As much as 400 mEq may be 
administered in a 24 hour period. In critical conditions, potassium chloride may 
be administered in saline (unless contraindicated), rather than in dextrose 
containing fluids, as dextrose may lower serum potassium levels.</p>
<p>Prior to entering vial, remove the metal seal and cleanse the rubber closure 
with a suitable antiseptic agent.</p>
<p>Parenteral drug products should be inspected visually for particulate matter 
and discoloration, whenever solution and container permit.</p>
<p>TO PREVENT NEEDLE-STICK INJURIES, NEEDLES SHOULD NOT BE RECAPPED, PURPOSELY 
BENT, OR BROKEN BY HAND.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-11"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Potassium Chloride for Injection Concentrate, USP, is supplied in 
single-dose containers as follows:</p>
<a name="i90c780fe-58a7-4e1d-8fbb-68626c09d4da"></a><table width="40%"><tbody class="Headless"><tr class="First Last">
<td>
<span class="Bold">NDC No.<br><br></span>524868-0767-1<br>
</td>
<td>
<span class="Bold">Type Container<br><br></span>Plastic Fliptop Vials<br>
</td>
<td>
<span class="Bold">Concentration<br><br></span>20 mEq/10 mL<br>
</td>
</tr></tbody></table>
<br><p>Store at controlled room temperature 15° to 30°C (59° to 86°F) [See USP.]</p>
<p>©Hospira 2004 EN-0069 Printed in USA<br></p>
<p><br></p>
<p>HOSPIRA, INC., LAKE FOREST, IL 60045 USA</p>
<span class="Italics"></span><p><br><span class="Italics"></span></p>
<p><br><span class="Italics"></span></p>
<p><br><span class="Italics"></span></p>
<p>Relabeling of "Additional Barcode" by:<br>Physicians Total Care, Inc.<br>Tulsa, OK      74146<br></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-12"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL</h1>
<p class="First">Potassium Chloride for Injection Concentrate, USP</p>
<p>20 mEq/10 mL</p>
<p><img alt="image of package label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7c390c7c-1a1d-4f8a-a83b-097179278b2a&amp;name=package%20label.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>POTASSIUM CHLORIDE 		
					</strong><br><span class="contentTableReg">potassium chloride injection, solution, concentrate</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:54868-0767(NDC:0409-6651)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>POTASSIUM CHLORIDE</strong> (POTASSIUM CATION) </td>
<td class="formItem">POTASSIUM CHLORIDE</td>
<td class="formItem">149 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>HYDROCHLORIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:54868-0767-1</td>
<td class="formItem">16  in 1 CASE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">25  in 1 CONTAINER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">10 mL in 1 VIAL</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA080205</td>
<td class="formItem">03/16/2007</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Physicians Total Care, Inc.
							(194123980)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Physicians Total Care, Inc.</td>
<td class="formItem"></td>
<td class="formItem">194123980</td>
<td class="formItem">relabel</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 5/2010<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>89085b2b-c676-4f2f-9ed4-2e04986fe137</div>
<div>Set id: 7c390c7c-1a1d-4f8a-a83b-097179278b2a</div>
<div>Version: 1</div>
<div>Effective Time: 20100526</div>
</div>
</div> <div class="DistributorName">Physicians Total Care, Inc.</div></p>
</body></html>
